partners

Written by Allan O'Bryan

Wednesday, 11 March 2009 15:54

World Sleep Day 2010 is a program of World Association of Sleep Medicine (WASM). WASM's fundamental mission is to advance sleep health worldwide. The World Sleep Day Committee is grateful to the 2010 World Sleep Day partners by providing financial and operating support of our mission. The partners of World Sleep Day 2010 celebrations are pharmaceutical companies, H. Lundbeck A/S and UCB Pharma SA.

About WASM WASM is an international organization comprised of healthcare professionals primarily active in the field of sleep medicine. The goal of WASM is to advance knowledge about sleep and sleep disorders among health care personnel and among the public worldwide. WASM was founded to improve sleep health worldwide and to encourage prevention and treatment of sleep disorders. We at the WASM are working toward increasing worldwide awareness of the importance of sleep and the adverse consequences resulting from lack of sleep, due either to enforced lifestyle or to sleep disorders themselves. The WASM aims to act as a link between various sleep associations and cultures, i.e., as an international nexus among sleep clinicians and researchers in the advancement of worldwide sleep health. A special goal of the Association is to foster dissemination of expertise in sleep medicine everywhere in the world.
About Lundbeck H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of drugs for the treatment of psychiatric and neurological disorders. In support of World Sleep Day, Lundbeck is undertaking insomnia awareness activities in countries across the world and has launched www.sleep-problems.com to provide more information to patients suffering from insomnia. In 2008, the company's revenue was DKK 11.3 billion (approximately EUR 1.5 billion or USD 2.2 billion). The number of employees is approx 5,500 globally. For more information, please visit www.lundbeck.com.
UCB, a biopharmaceutical company headquartered in Belgium is dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology. UCB is committed to improving the lives of the patients who inspire us and also develops meaningful support programs to enable patients, carers, and healthcare professionals to work together to overcome the everyday challenges of living with severe diseases

< Prev		Next >

Last Updated ( Thursday, 11 March 2010 23:22 )